scholarly journals Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Nina Sanina ◽  
Natalia Chopenko ◽  
Andrey Mazeika ◽  
Eduard Kostetsky

New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) fromCucumaria japonicaand monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund’s adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes.

2020 ◽  
Vol 4 (4) ◽  
pp. 5-11
Author(s):  
Ioanna Zerva ◽  
Vasileia Pateraki ◽  
Irene Athanassakis

Effective and side-effect-free vaccines are still difficult tasks to achieve for a great majority of antigenic stimuli. Pathogen manipulation to abort infectivity and antigen delivery to ensure immune responsiveness are the major components vaccine technology tries to resolve. However, the development of an immune response is still a complicated matter, lies on hundreds of parameters and any effort towards activation can easily lead to adverse effects, making immunotherapy very difficult to control. The present review attempts to highlight the major parameters affecting immune responsiveness and show that vaccine technology, except from pathogen manipulation and the development of antigen delivery systems, requires attention to additional check-points. Analyzing the recently described personalized implantable vaccine technology, it becomes obvious that the nature of each antigenic stimulus dictates different responsiveness to the organism, which discourages the use of universal adjuvant and antigen-delivery systems. On the contrary, the ex vivo tuning of the immune response proposed by the implantable vaccine technology, allows controllable amendment of the response. The development of personalized technologies is expected to provide valuable tools for the management of human pathology.


2005 ◽  
pp. 987-1007 ◽  
Author(s):  
Suzanne M. Michalek ◽  
Derek T. O'Hagan ◽  
Noel K. Childers ◽  
Albert D.M.E. Osterhaus ◽  
Guus F. Rimmelzwaan

2016 ◽  
Vol 46 (4) ◽  
pp. 295-304 ◽  
Author(s):  
Joo Yeon Park ◽  
Mi-Gyeong Kim ◽  
Gayong Shim ◽  
Yu-Kyoung Oh

2005 ◽  
Vol 57 (3) ◽  
pp. 333-355 ◽  
Author(s):  
T STORNI ◽  
T KUNDIG ◽  
G SENTI ◽  
P JOHANSEN

Vaccine ◽  
2008 ◽  
Vol 26 (51) ◽  
pp. 6508-6528 ◽  
Author(s):  
Alejandro Brun ◽  
Emmanuel Albina ◽  
Tom Barret ◽  
David A.G. Chapman ◽  
Markus Czub ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document